Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
USH | Ann: USH NTA 29-07-2025 $3.57789 | 30/07/25 | 0 | 29 | |||
|
|||||||
USH | Ann: USH NTA 28-07-2025 $3.57881 | 29/07/25 | 0 | 50 | |||
|
|||||||
USH | Ann: USH NTA 25-07-2025 $3.56509 | 28/07/25 | 0 | 39 | |||
|
|||||||
USH | Ann: USH NTA 24-07-2025 $3.56300 | 25/07/25 | 0 | 60 | |||
|
|||||||
USH | Ann: USH NTA 23-07-2025 $3.53330 | 24/07/25 | 0 | 57 | |||
|
|||||||
USH | Ann: USH NTA 22-07-2025 $3.53360 | 23/07/25 | 0 | 42 | |||
|
|||||||
USH | Ann: USH NTA 21-07-2025 $3.52752 | 22/07/25 | 0 | 59 | |||
|
|||||||
USH | Ann: USH NTA 18-07-2025 $3.53009 | 21/07/25 | 0 | 52 | |||
|
See All Discussions